环磷酰胺与癸酸诺龙治疗晚期乳腺癌——单药及联合用药对比对照试验结果
Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.
作者信息
Cole M P, Todd I D, Wilkinson P M
出版信息
Br J Cancer. 1973 May;27(5):396-9. doi: 10.1038/bjc.1973.47.
Abstract
A random trial in which cyclophosphamide, nandrolone decanoate and the two drugs in combination were used in the treatment of advanced breast carcinoma is described. The results suggest that it is preferable to use cyclophosphamide on its own.
摘要
描述了一项随机试验，其中使用环磷酰胺、癸酸诺龙以及两种药物联合用于治疗晚期乳腺癌。结果表明单独使用环磷酰胺更可取。
相似文献
1
Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.环磷酰胺与癸酸诺龙治疗晚期乳腺癌——单药及联合用药对比对照试验结果
Br J Cancer. 1973 May;27(5):396-9. doi: 10.1038/bjc.1973.47.
2
Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
Cancer. 1986 Jul 1;58(1):183-6. doi: 10.1002/1097-0142(19860701)58:1<183::aid-cncr2820580131>3.0.co;2-3.
3
[Androgen therapy of incurable breast neoplasms. Controlled clinical study: nandrolone-testololactone-drostanolone].[不可治愈性乳腺肿瘤的雄激素治疗。对照临床研究：南诺龙 - 睾酮内酯 - 去氢表雄酮]
Onkologie. 1978 Aug;1(4):172-4. doi: 10.1159/000213943.
4
Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
Breast Cancer Res Treat. 1985;5(1):75-80. doi: 10.1007/BF01807653.
5
The effect of nandrolone decanoate on bone marrow suppression induced by cytostatic agents.癸酸诺龙对细胞毒性药物所致骨髓抑制的影响。
Clin Oncol. 1976 Sep;2(3):207-14.
6
[Apropos of intra-arterial chemotherapy in the treatment of breast cancers].[关于动脉内化疗在乳腺癌治疗中的应用]
Mem Acad Chir (Paris). 1966 Dec 14;92(31):879-90.
7
Effect of nandrolone phenylpropionate (NSC-23162e) on the bone marrow suppression caused by cyclophosphamide (NSC-26271): a clinical trial.苯丙酸诺龙（NSC - 23162e）对环磷酰胺（NSC - 26271）所致骨髓抑制的影响：一项临床试验
Cancer Chemother Rep. 1974 Nov-Dec;58(6):867-70.
8
Some aspects of chemotherapy in breast carcinomatosis.乳腺癌转移的化疗的某些方面。
Clin Radiol. 1968 Jul;19(3):351-6. doi: 10.1016/s0009-9260(68)80029-7.
9
Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumors.低剂量甲氨蝶呤（NSC-740）和环磷酰胺（NSC 26271）用于实体瘤。
Cancer Chemother Rep. 1970 Feb;54(1):41-6.
引用本文的文献
1
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.转移性乳腺癌单纯化疗与单纯内分泌治疗的比较
Cochrane Database Syst Rev. 2003;2003(2):CD002747. doi: 10.1002/14651858.CD002747.
本文引用的文献
1
Activation of cyclophosphamide in man and animals.
Cancer. 1971 Jun;27(6):1512-29. doi: 10.1002/1097-0142(197106)27:6<1512::aid-cncr2820270636>3.0.co;2-q.
2
Effect of steroid hormone on activation of Endoxan (cyclophosphamide).类固醇激素对癌得星（环磷酰胺）激活的影响。
Biochem Pharmacol. 1969 Jan;18(1):129-35. doi: 10.1016/0006-2952(69)90017-3.
Zotero 插件